Del P. Casado-Briceno
Cadiz, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 12, 2025
Methodological interpretation of subgroup analysis by histological subtype for perioperative toripalimab in resectable non-small-cell lung cancer.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 06, 2025
Methodological interpretation of subgroup analysis by histological subtype for perioperative toripalimab in resectable non-small-cell lung cancer.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 06, 2025
Network meta-analysis of perioperative immunotherapies in non-small-cell lung cancer according to tumor programmed death ligand 1 expression.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: February 04, 2025
[Translated article] Network meta-analysis of perioperative immunotherapies in non-small-cell lung cancer according to tumor programmed death ligand 1 expression.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: February 04, 2025
Immunotherapy in advanced endometrial cancer with microsatellite instability: A systematic review.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: January 16, 2025
[Translated article] Clinical decision making on retreatment with monoclonal antibodies in chronic/episodic migraine.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: August 27, 2024
Biomarker Analysis of Vistusertib Plus Paclitaxel Regimen.
Journal: JAMA oncology
Published: September 07, 2023
Long-lasting effect of belantamab mafodotin in heavily pretreated multiple myeloma.
Journal: Indian journal of pharmacology
Published: December 20, 2022
Patient benefit as a goal of humanization.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: December 15, 2022
Inclusion of omalizumab in a trastuzumab desensitization protocol.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: October 02, 2022
Last Updated: 09/26/2026